Paul Sauer - Aug 22, 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
SVP Process Dev, Manufacturing
Signature
Paul Sauer, by /s/ Ron Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Aug 22, 2022
Transactions value $
-$77,785
Form type
4
Date filed
8/24/2022, 04:47 PM
Previous filing
Jul 29, 2022
Next filing
Sep 7, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Sale -$77.8K -3K -16.96% $25.93 14.7K Aug 22, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported is a weighted-average price. The shares were sold at prices ranging from $25.685 to $26.09. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.